Table 1.
Baseline characteristics by height (prevalent analysis group)
| Group | Characteristic | Group 1 | Group 2 | Group 3 | Group 4 | Group 5 |
|---|---|---|---|---|---|---|
| Women (n = 3378) | Height (cm) | ≤150 | 150–155 | 155–160 | 160–165 | >165 |
| Number | 255 | 667 | 1116 | 820 | 520 | |
| Mean height in cm (SD) | 147 (3) | 153 (1) | 158 (1) | 163 (1) | 169 (3) | |
| Mean age in years (SD) | 75.6 (6.2) | 73.8 (5.7) | 72.6 (5.5) | 71.5 (4.9) | 71.0 (4.5) | |
| Black race (%) | 34 (13) | 110 (17) | 189 (17) | 144 (18) | 102 (20) | |
| Income (% below median)† | 160 (63) | 352 (53) | 549 (49) | 358 (44) | 216 (42) | |
| Education (% HS grad or better)† | 162 (64) | 437 (66) | 770 (69) | 627 (76) | 393 (76) | |
| Diabetes (%) | 34 (13) | 88 (13) | 175 (16) | 104 (13) | 84 (16) | |
| CHD (%) | 41 (16) | 133 (20) | 160 (14) | 123 (15) | 65 (13) | |
| Current smoking (%) | 23 (9) | 79 (12) | 136 (12) | 117 (14) | 67 (13) | |
| Treated HTN (%)* | 189 (74) | 489 (73) | 745 (67) | 501 (61) | 328 (63) | |
| CVA (%) | 11 (4) | 24 (4) | 31 (3) | 21 (3) | 17 (3) | |
| Mean BMI (SD) | 27.4 (5.7) | 27.1 (5.3) | 27.1 (5.3) | 26.5 (5.2) | 26.9 (5.3) | |
| Mean SBP in mmHg (SD) | 140 (22) | 140 (22) | 138 (22) | 134 (22) | 135 (23) | |
| Mean creatinine in mg/dL (SD) | 0.94 (0.35) | 0.92 (0.25) | 0.94 (0.28) | 0.94 (0.26) | 0.94 (0.21) | |
| Mean LA diameter in cm (SD) | 3.83 (0.75) | 3.76 (0.65) | 3.77 (0.64) | 3.76 (0.63) | 3.83 (0.67) | |
| Mean NT-proBNP in pg/dL (SD) | 430 (1420) | 271 (728) | 260 (484) | 199 (370) | 256 (569) | |
| Men (n = 2482) | Height (cm) | ≤165 | 165–170 | 170–175 | 175–180 | >180 |
| Number | 280 | 547 | 734 | 578 | 343 | |
| Mean height in cm (SD) | 162 (3) | 168 (1) | 173 (1) | 177 (1) | 184 (3) | |
| Mean age in years (SD) | 75.7 (6.4) | 74.1 (6.0) | 73.1 (5.4) | 72.5 (5.4) | 71.7 (5.1) | |
| Black race (%) | 37 (13) | 67 (12) | 111 (15) | 82 (14) | 48 (14) | |
| Income (% below median)† | 111 (40) | 192 (35) | 244 (33) | 160 (28) | 77 (22) | |
| Education (% HS grad or better)† | 173 (62) | 378 (69) | 518 (71) | 399 (69) | 274 (80) | |
| Diabetes (%) | 50 (18) | 98 (18) | 131 (18) | 124 (21) | 72 (21) | |
| CHD (%) | 78 (28) | 152 (28) | 166 (23) | 144 (25) | 74 (22) | |
| Current smoking (%) | 25 (9) | 69 (13) | 73 (10) | 68 (12) | 37 (11) | |
| Treated HTN (%)* | 195 (70) | 382 (70) | 474 (65) | 359 (62) | 202 (59) | |
| CVA (%) | 22 (8) | 35 (6) | 43 (6) | 23 (4) | 16 (5) | |
| Mean BMI (SD) | 26.6 (4.0) | 26.8 (4.1) | 26.4 (3.6) | 26.3 (3.6) | 26.3 (4.0) | |
| Mean SBP in mmHg (SD) | 140 (23) | 137 (21) | 137 (21) | 134 (22) | 132 (19) | |
| Mean creatinine in mg/dL (SD) | 1.23 (0.33) | 1.24 (0.33) | 1.25 (0.32) | 1.23 (0.29) | 1.19 (0.25) | |
| Mean LA diameter in cm (SD) | 3.96 (0.69) | 4.07 (0.71) | 4.03 (0.66) | 4.04 (0.66) | 4.10 (0.70) | |
| Mean NT-proBNP in pg/dL (SD) | 334 (596) | 392 (871) | 348 (1144) | 291 (752) | 246 (452) |
All tests of heterogeneity had 4 degrees of freedom.
*P < 0.005 (χ2 test).
†P < 0.0001 (χ2 test).